Science Explorer Back to mapMap
Discussion
Institution · German National Bone Marrow Donor Registry

Most cited papers from German National Bone Marrow Donor Registry

German National Bone Marrow Donor Registry

What are the most cited papers from German National Bone Marrow Donor Registry?

The most cited paper from German National Bone Marrow Donor Registry is "Nomenclature for Factors of the HLA System, 2026" (Steven G.E. Marsh et al., 2010), with 4,206 citations. Next come "Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial" (404) and "The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy" (367).

Showing 50 of 59 papers. Every paper with more than 54 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Nomenclature for Factors of the HLA System, 2026 Steven G.E. Marsh et al. · Tissue Antigens Open access 17 Mar 2010 4,206
2 Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial Christoph Röllig et al. · The Lancet Oncology Open access 5 Nov 2015 404
3 The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy Craig Kollman et al. · Blood Open access 2 Nov 2015 367
4 Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR Jason G. Dehn, Stephen R. Spellman, Carolyn Katovich Hurley et al. · Blood Open access 10 Jul 2019 325
5 Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation Joseph Pidala et al. · Blood Open access 27 Aug 2014 283
6 Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing Vinzenz Lange, Irina Böhme, Jan A. Hofmann et al. · BMC Genomics Open access 24 Jan 2014 283
7 Donor leukocyte infusions in acute lymphocytic leukemia RH Collins, Steven C. Goldstein, Sergio A. Giralt et al. · Bone Marrow Transplantation 31 Aug 2000 244
8 Common and well‐documented HLA alleles: 2012 update to the CWD catalogue Steven J. Mack et al. · Tissue Antigens Open access 20 Mar 2013 235
9 CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT Martin Schmidt‐Hieber, Myriam Labopin, Dietrich Wilhelm Beelen et al. · Blood 14 Sep 2013 226
10 Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors Kristina Hölig, Michael Krämer, Frank Kroschinsky et al. · Blood Open access 8 Aug 2009 224
11 Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. W J Murphy, L A Welniak, Dennis D. Taub et al. · Journal of Clinical Investigation Open access Nov 1998 222
12 Apoptosis and immunohistochemicalbcl-2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance Gustavo Bruno Baretton, Joachim Diebold, Gregor Christoforis et al. · Cancer Open access 15 Jan 1996 220
13 High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis Daniel E Furst, Carlheinz Müller, Vladan Vučinić et al. · Blood 17 Sep 2013 210
14 DQB1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy with Cataplexy in Europe Behalf of the European Narcolepsy Network (EU-NN) et al. · SLEEP Open access 2014 202
15 Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? Peter Dreger, Johannes Schetelig, Niels Smedegaard Andersen et al. · Blood Open access 10 Oct 2014 200
16 Cause of death in adults with congenital heart disease — An analysis of the German National Register for Congenital Heart Defects Claudia C. Engelings, P. Helm, Hashim Abdul‐Khaliq et al. · International Journal of Cardiology 2 Mar 2016 196
17 Kit Regulates HSC Engraftment across the Human-Mouse Species Barrier Kadriye Nehir Cosgun, Susann Rahmig, Nicole Mende et al. · Cell stem cell Open access 10 Jul 2014 194
18 Mutations in the Sarcomere Gene MYH7 in Ebstein Anomaly Alex V. Postma, Klaartje van Engelen, Judith van de Meerakker et al. · Circulation Cardiovascular Genetics Open access 3 Dec 2010 188
19 Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0 Carolyn Katovich Hurley et al. · HLA Open access 22 Jan 2020 181
20 Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation. Mortimer M. Bortin, Alfred A. Rimm · PubMed 15 Aug 1977 174
21 A perspective on the selection of unrelated donors and cord blood units for transplantation Stephen R. Spellman, Mary Eapen, Brent R. Logan et al. · Blood Open access 18 May 2012 148
22 National Marrow Donor Program HLA Matching Guidelines for Unrelated Adult Donor Hematopoietic Cell Transplants Robert A. Bray, Carolyn Katovich Hurley, Naynesh R. Kamani et al. · Transplantation and Cellular Therapy Open access Sep 2008 144
23 Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning Alexander H. Schmidt, Daniel M Baier, Ute V. Solloch et al. · Human Immunology 14 Aug 2009 135
24 Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation Christoph Schmid et al. · Haematologica Open access 3 Nov 2017 131
25 HEMORRHAGIC CYSTITIS AFTER BONE MARROW TRANSPLANTATION RISK FACTORS AND COMPLICATIONS Susan Sencer, Robert J. Haake, Daniel Jordan Weisdorf · Transplantation Oct 1993 130
26 Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome Éliane Gluckman, MM Horowitz, RE Champlin et al. · Blood Open access 1992 124
27 Spleen enlargement in healthy donors during G–CSF mobilization of PBPCs Uwe Platzbecker, Gabriele Prange‐Krex, Martin Bornhäuser et al. · Transfusion Feb 2001 121
28 Allogeneic Bone Marrow Transplantation for 144 Patients With Severe Aplastic Anemia Mortimer M. Bortin · JAMA 20 Mar 1981 121
29 Lifespan Perspective on Congenital Heart Disease Research Gerhard‐Paul Diller, Alexandra Arvanitaki, Alexander R. Opotowsky et al. · Journal of the American College of Cardiology Open access 27 Apr 2021 113
30 Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects Gerhard‐Paul Diller, Marc-André Körten, Ulrike M. M. Bauer et al. · European Heart Journal Open access 2 Feb 2016 111
31 Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase Nael Alakel, Jan Moritz Middeke, Johannes Schetelig et al. · OncoTargets and Therapy Open access Feb 2017 110
32 Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia Francesco Frassoni, Myriam Labopin, R Powles et al. · The Lancet Apr 2000 106
33 Gene and haplotype frequencies for the loci hLA-A, hLA-B, and hLA-DR based on over 13,000 german blood donors Carlheinz Müller, Gerhard Ehninger, Shraga F. Goldmann · Human Immunology 30 Dec 2002 106
34 Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Nicolaus Kr�ger, M. Bornh�user, Gerhard Ehninger et al. · Annals of Hematology Jun 2003 102
35 High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies Peter Dreger, Paolo Ghia, Johannes Schetelig et al. · Blood Open access 11 Jul 2018 101
36 TP 53 mutation in patients with high‐risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation Jan Moritz Middeke et al. · British Journal of Haematology Open access 13 Jan 2016 101
37 Hepatocytic gene expression in cultured rat mesenchymal stem cells Claudia Lange, Philipp Bassler, Michael V. Lioznov et al. · Transplantation Proceedings 2005 91
38 Estimation of HLA-A, -B, -DRB1 Haplotype Frequencies Using Mixed Resolution Data from a National Registry with Selective Retyping of Volunteers Craig Kollman, Martin J. Maiers, Loren A. Gragert et al. · Human Immunology Dec 2007 90
39 Common and well‐documented HLA alleles over all of Europe and within European sub‐regions: A catalogue from the European Federation for Immunogenetics Alicia Sanchez‐Mazas, José Manuel Nunes, Derek Middleton et al. · HLA Open access 18 Jan 2017 89
40 Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity Mehdi Tafti et al. · SLEEP Open access 29 Feb 2016 85
41 “Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries” Mahmoud Deeb Aljurf et al. · Bone Marrow Transplantation Open access 18 Feb 2019 82
42 High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: How can they be used to improve unrelated donor searches? Julia Pingel, Ute V. Solloch, Jan A. Hofmann et al. · Human Immunology 29 Nov 2012 76
43 Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study Gerhard‐Paul Diller, Stefan Orwat, Astrid Elisabeth Lammers et al. · European Heart Journal 24 Jun 2021 75
44 Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation Jan Moritz Middeke, Min Fang, Jan J. Cornelissen et al. · Blood 21 Mar 2014 74
45 HLA‐B*57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans Maja Mockenhaupt, Chuang‐Wei Wang, Wen‐Hung Chung et al. · Allergy Open access 11 Apr 2019 72
46 Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis Astrid Elisabeth Lammers, Gerhard‐Paul Diller, Rieke Lober et al. · European Heart Journal 8 Sep 2021 71
47 CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo Nicole Mende, Erika E Kuchen, Mathias Lesche et al. · The Journal of Experimental Medicine Open access 6 Jul 2015 69
48 Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string Robert P. Milius, Steven J. Mack, Jill A. Hollenbach et al. · Tissue Antigens Open access 12 Jul 2013 66
49 Haplobanking induced pluripotent stem cells for clinical use Stephen K. Sullivan, Paul J. Fairchild, Steven G. E. Marsh et al. · Stem Cell Research Open access 28 Oct 2020 64
50 Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT Silke Heidenreich et al. · Transplantation and Cellular Therapy Open access 9 Oct 2016 64

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.